Atgam equine and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Atgam equine and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lymphocyte immune globulin, anti-thy (equine)
Brand name: Atgam
Synonyms: Atgam (equine), Atgam
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Atgam equine-Insulin glargine, recombinant Subcutaneous
- Atgam equine-Insulin glulisine
- Atgam equine-Insulin Glulisine (Cartridges and Pens)
- Atgam equine-Insulin Glulisine (Vials)
- Atgam equine-Insulin glulisine Subcutaneous
- Atgam equine-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Ativan
- Insulin glargine and lixisenatide Subcutaneous-Ativan (Lorazepam Injection Solution)
- Insulin glargine and lixisenatide Subcutaneous-Ativan (Lorazepam Tablets)
- Insulin glargine and lixisenatide Subcutaneous-Ativan injection
- Insulin glargine and lixisenatide Subcutaneous-Ativan Tablets
- Insulin glargine and lixisenatide Subcutaneous-ATNAA